MSK-IMPACT Pan-Cancer Data for Primary and Metastatic Tumors

Pan-cancer genomic data for primary and metastatic tumors derived from the public MSK-IMPACT 2017 cohort on cBioPortal. The dataset was uploaded by an author named Zhang and is available under a CC-BY-4.0 license. It was last updated on May 24, 2026.

Use Cases

• Compare genomic alterations between primary and metastatic tumors based on the pan-cancer scope.
• Analyze tumor evolution and heterogeneity using data from the MSK-IMPACT clinical sequencing cohort.
• Validate biomarkers for metastatic potential across multiple cancer types based on the cohort's data.

Strengths

• Derived from the well-known MSK-IMPACT clinical sequencing cohort, a public resource in cancer genomics.
• Explicitly includes data for both primary and metastatic tumor sites, enabling comparative analysis.
• Available under a permissive CC-BY-4.0 license for broad reuse.

Limitations

• The dataset is small at 1.0 MB, suggesting it may be a subset or summary rather than the full genomic data.
• Column-level documentation and row count are unknown, requiring manual inspection after download.
• Description metadata is limited; actual data quality and completeness require verification.

Provenance

Source

MSK-IMPACT cohort from cBioPortal for Cancer Genomics.

Collection Method

Publicly available clinical sequencing data, likely aggregated and processed by the author.

Freshness

Last updated 2026-05-24 20:46:29; freshness should be verified.